Colostomy

3
Pipeline Programs
2
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

ConvaTec
ConvaTecNJ - Bridgewater
4 programs
1
1
UsualPhase 31 trial
One piece closed pouchPhase 21 trial
Esteem Plus with ConvaTec Moldable TechnologyN/A1 trial
VitalaTMN/A1 trial
Active Trials
NCT01207479CompletedEst. Nov 2010
NCT01935999CompletedEst. Jul 2013
+1 more trials
C
ColoplastAustralia - Mulgrave
2 programs
1
SSPhase 2/31 trial
MorfeusN/A1 trial
Active Trials
NCT01273038CompletedEst. Mar 2011
NCT01243294CompletedEst. Nov 2010

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ConvaTecUsual
ColoplastSS
ConvaTecOne piece closed pouch
ConvaTecEsteem Plus with ConvaTec Moldable Technology
ColoplastMorfeus
ConvaTecVitalaTM

Clinical Trials (6)

Multi-National Phase III Vitala™ 12-Hour Wear Test

Start: Apr 2009Est. completion: Jan 2010
Phase 3Completed

Study Evaluating a New Ostomy Appliance With Regard to Leakage, Handling and Comfort

Start: Aug 2010Est. completion: Nov 2010
Phase 2/3Completed
NCT01935999ConvaTecOne piece closed pouch

One Piece Closed Pouch in Subjects With a Colostomy

Start: Jun 2013Est. completion: Jul 2013
Phase 2Completed
NCT02499588ConvaTecEsteem Plus with ConvaTec Moldable Technology

User Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™

Start: Jun 2015
N/AUnknown

Clinical Investigation for New Filter to Ostomy Bags

Start: Jan 2011Est. completion: Mar 2011
N/ACompleted

Study to Assess the Safety and Performance of The VitalaTM Continence Control Device With Natura Moldable Skin Barriers

Start: Sep 2010Est. completion: Nov 2010
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space